当前位置:首页 - 行情中心 - 莱茵生物(002166) - 财务分析 - 现金流量表

莱茵生物

(002166)

  

流通市值:36.39亿  总市值:60.29亿
流通股本:4.48亿   总股本:7.42亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金594,106,387.961,888,280,454.121,438,826,870.38995,017,866.44
收到的税费返还6,313,359.9570,908,816.4566,130,272.4452,061,988.25
收到其他与经营活动有关的现金3,670,545.8722,652,31816,738,483.9712,515,446.51
经营活动现金流入的平衡项目0000
经营活动现金流入小计604,090,293.781,981,841,588.571,521,695,626.791,059,595,301.2
购买商品、接受劳务支付的现金326,250,630.191,415,577,326.371,047,088,689.31779,012,147.79
支付给职工以及为职工支付的现金57,265,330.15185,707,033.63136,483,035.2292,039,609.28
支付的各项税费17,422,333.6753,134,538.1836,851,920.4726,225,151.56
支付其他与经营活动有关的现金20,215,885.78167,709,093.35158,535,527.71132,700,934.43
经营活动现金流出的平衡项目0000
经营活动现金流出小计421,154,179.791,822,127,991.531,378,959,172.711,029,977,843.06
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额182,936,113.99159,713,597.04142,736,454.0829,617,458.14
二、投资活动产生的现金流量:
收回投资收到的现金36,454.084,124,071.862,496,073.11-
取得投资收益收到的现金-7,362,916.27,362,916.1249,563.12
处置固定资产、无形资产和其他长期资产收回的现金净额103,348109,03059,48024,308
投资活动现金流入的平衡项目0000
投资活动现金流入小计139,802.0811,596,018.069,918,469.2373,871.12
购建固定资产、无形资产和其他长期资产支付的现金53,324,549.53207,081,135.72157,657,032.66107,889,752.92
投资活动现金流出的平衡项目0000
投资活动现金流出小计53,324,549.53207,081,135.72157,657,032.66107,889,752.92
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-53,184,747.45-195,485,117.66-147,738,563.43-107,815,881.8
三、筹资活动产生的现金流量:
取得借款收到的现金291,889,156.5942,894,636833,756,045538,076,045
收到其他与筹资活动有关的现金5,099,252319,100,00018,900,00018,900,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计296,988,408.51,261,994,636852,656,045556,976,045
偿还债务支付的现金211,020,092.5703,570,255498,584,059214,675,111
分配股利、利润或偿付利息支付的现金11,355,735.38190,320,195.79179,781,071.39166,475,299.97
支付其他与筹资活动有关的现金46,523,380.21397,863,799.9284,937,059.3672,228,633.61
筹资活动现金流出平衡项目0000
筹资活动现金流出小计268,899,208.091,291,754,250.71763,302,189.75453,379,044.58
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额28,089,200.41-29,759,614.7189,353,855.25103,597,000.42
四、汇率变动对现金及现金等价物的影响882,805.761,636,118.971,297,474.72993,987.76
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额158,723,372.71-63,895,016.3685,649,220.6226,392,564.52
加:期初现金及现金等价物余额49,769,406.35113,664,422.71113,664,422.71113,664,422.71
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额208,492,779.0649,769,406.35199,313,643.33140,056,987.23
补充资料:
净利润-167,173,992.57-67,995,492.28
资产减值准备-21,463,296.06--2,610,068.48
固定资产和投资性房地产折旧-94,197,003.43-42,478,278.67
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-94,197,003.43-42,478,278.67
无形资产摊销-4,589,958.37-2,218,013.59
长期待摊费用摊销-4,253,880.75-2,690,507.74
处置固定资产、无形资产和其他长期资产的损失-523,831.47-8,561
固定资产报废损失-1,116,976.43-571,015.99
公允价值变动损失--2,025,062.21-4,502,537.93
财务费用-41,281,141.03-18,557,483.53
投资损失--7,178,829--7,362,916.12
递延所得税-951,847.94-452,468.66
其中:递延所得税资产减少--2,820,177.9--1,909,404.64
递延所得税负债增加-3,772,025.84-2,361,873.3
存货的减少--237,129,675--277,353,623.89
经营性应收项目的减少-8,251,296.59-198,579,865.41
经营性应付项目的增加-42,370,133.3--22,831,180.58
其他-16,076,345.8--
现金的期末余额-49,769,406.35-140,056,987.23
减:现金的期初余额-113,664,422.71-113,664,422.71
公告日期2025-04-262025-03-282024-10-312024-08-29
审计意见(境内)标准无保留意见
TOP↑